Propel testing excellence with Mayo Clinic quality
Mayo Clinic Laboratories is a one-stop laboratory solution, offering commercial laboratories a vast testing menu, unparalleled customer service, and optimized processes. We work collaboratively with partners to assess their needs, providing the testing they need to expand into new areas and meet their business goals.
As the reference lab for Mayo Clinic, we’ve developed robust logistics and testing protocols applied uniformly for all specimens received, no matter their geographic origin. Whether you send us one test order or thousands, each sample receives the same treatment and level of care, ensuring superior results that help our partners better serve their clients.
“Our clients want personal experiences. They want someone to answer the phone. They want someone to provide answers when they're looking for results of a sample sent a couple days ago. and we deliver those answers.”
Angie Reese-Davis, director of operations, logistics, and specimen services, Mayo Clinic Laboratories
Our difference
News and updates
The latest
In this episode of the “Leveraging the Laboratory” podcast, Jane Hermansen, outreach manager at Mayo Clinic Laboratories, welcomes Chelsea Conn, Mayo Clinic Laboratories’ director of regulatory affairs. Together, they break down the latest regulatory changes and share actionable strategies to help outreach programs stay informed and prepared.
Today's highlights include: Study mines cancer genetics to help with targeted treatment, Mayo Clinic to launch staffing tool app to find 'right nurse for the right role', and new blood biomarker may lead to early diagnosis of frontotemporal dementia.
Justin Kreuter, M.D., sits down with Curt Hanson, M.D., professor of Laboratory Medicine and Pathology, a hematopathology consultant at Mayo Clinic, and executive vice president and chief medical officer for Mayo Collaborative Services, to celebrate Lab Week 2022 and discuss why it’s important to look at our past when planning for the future.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. In this episode, Dr. Morice and Dr. Pritt look at current trends in COVID-19 cases and hospitalizations, and they discuss advances in diagnosing the virus.
Joel Cayou’s goal as a supervisor in Specimen Handling is to support his staff wherever he can in the vital work they do to keep Mayo Clinic Laboratories’ operations running efficiently.
Mayo Clinic recently announced plans to invest in an expansion project to enhance laboratory medicine. The expansion project will support Mayo Clinic Laboratories' goal to provide diagnostics to Mayo Clinic patients throughout the nation and abroad. Health care teams around the world will have access to laboratory testing through Mayo Clinic Laboratories' Test Catalog, and Mayo Clinic patients will have access to testing via their Mayo Clinic health care providers.
In this test specific episode of the "Answers From the Lab" podcast, Melissa Snyder, Ph.D., explains how IBDP2, when used after first-line testing has failed, can distinguish between ulcerative colitis and Crohn’s disease.
Top highlights include: Advances in neuroimaging for brain charts for the human lifespan.
Topics include: Why women's risk of heart disease increased during the pandemic and information about the most commonly asked questions for when to get your second COVID-19 booster.
Today's highlights include: Facing 'alarming' health care worker shortage, unusual cases of hepatitis in young children, and why women's risk of heart disease increased during the pandemic.
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Mayo Clinic Laboratories’ manager of Outreach and Network Support, Jane Hermansen, to celebrate laboratory successes from the past and look toward the future.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. In this episode, Dr. Morice and Dr. Pritt explain what it means for a clinical laboratory to be licensed by CLIA (Clinical Laboratory Improvement Amendments), and discuss the important role of the lab director in a CLIA laboratory.
The considerations physicians must weigh when evaluating suspected neuropathy patients with special emphasis put on small-fiber neuropathy and the most appropriate laboratory testing related to that phenotype.